Categories



TheLibertyMill




The Phaserl








AvatarProducts

Big Pharma digs its claws deeper into academia under guise of research

by Ethan A. Huff, Natural News:

Because the company has been unable to develop a steady stream of new “blockbuster” drugs on its own, London-based pharmaceutical giant AstraZeneca has decided to expand its corporate reach by essentially merging itself with the publicly-funded academic realm. Reuters reports that AstraZeneca has made available to British academic researchers a slew of compounds that, as of yet, have no formidable uses within the drug industry, but that will be investigated using taxpayer dollars for the purpose of turning them into marketable drugs.

Framed by the media as a benevolent offering by AstraZeneca, the so-called “donation” of these compounds to academic research is actually nothing more than a sly business venture by the company to capitalize on the manpower of the taxpayer-funded research community. By securing more than $11 million in funding from the Medical Research Council (MRC), the academic community will be able to conduct research for AstraZeneca on the taxpayers’ dime, which will in turn lead to the development of new, for-profit pharmaceutical drugs.

Read More @ NaturalNews.com

Help us spread the ANTIDOTE to corporate propaganda.

Please follow SGT Report on Twitter & help share the message.

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>